Shukra Pharmaceuticals Q2 Results

  • BSE: 524632
  • NSE: -
  • ISIN: INE551C01044
  • Sector: Biotechnology & Drugs
BSE
31.870.41 (1.30%)
Volume1.27 M
Updated: Mon 8 Jun, 2026 | 15:56:20
NSE
This stock is not traded on NSE
Today: 30.26
34.34
52-Wk: 12.97
65.26

Q2 Results Highlights

Quarter ended Sep 25

    Note: Comparison is on QoQ basis

    Quarterly - Shukra Pharmaceuticals Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 25Jun 25QoQ CompSep 24YoY Comp
    Total Operating Expense 7.114.8646.24%5.5927.21%
    Depreciation/ Amortization 0.810.792.79%0.7015.90%
    Operating Income -1.230.530.00%-0.033814.65%
    Net Income 2.381.03130.99%0.54341.27%
    Other Operating Expenses Total 2.101.4842.10%1.0894.16%
    Net Income Before Taxes 0.201.37-85.55%0.87-77.32%
    Total Revenue 5.885.399.02%5.565.80%
    Selling/ General/ Admin Expenses Total 2.191.8220.19%1.4353.48%
    Diluted Normalized EPS 0.050.02150.00%0.01306.17%
    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market